Battle against Preeclampsia: Where Do We Stand Today?
Rebecca Khan, MD, FACOG
Lab-developed, FDA-cleared assays that use validated biomarkers could help detect and manage preeclampsia
Women's Health
2024 Women in Leadership Digital Forum
Today's Clinical Lab
Join Today's Clinical Lab and our experts for our Women in Leadership Digital Forum on April 2, 2024
Noninvasive Fetal Screening Effectively Detects Abnormalities
Massachusetts General Hospital
Noninvasive method has the potential to survey the entire fetal exome without the need for amniocentesis
US Newborn Syphilis Cases See 10x Spike Over a Decade
Centers for Disease Control and Prevention
Almost 9 in 10 newborn syphilis cases in 2022 might have been prevented with timely testing and treatment during pregnancy
How NGS-Based Testing Can Advance Reproductive Health Research
Kathy Davy, MBA
High throughput, reliability, sensitivity, and accuracy make NGS a robust reproductive health tool
The Influence of Race on Noninvasive Prenatal Testing
Raeesa Gupte, PhD
Limited inclusion of Black patients with comorbidities or preexisting health conditions represents an important gap in NIPT research
Antibody-Drug Conjugate Benefits HER2-Low Breast Cancers
German Institute for Quality and Efficiency in Health Care (IQWiG)
Patients with HER2-low breast cancers were included in the clinical trial proving the efficacy of trastuzumab deruxtecan monotherapy
New Hepatitis E, Diabetes Tests Included in WHO’s Essential Diagnostics Lists
World Health Organization
EDLs will help countries develop national and international IVD policies to deliver better patient care
EPOCH Trial to Explore Ovarian, Uterine Carcinosarcoma Therapies
Walter and Eliza Hall Institute
International clinical trial exploring treatment combinations for rare and aggressive cancers in women launched in Australia
New Prediction Model Aids in Early Detection of Preeclampsia
Swathi Kodaikal, MSc
The model analyzes methylation changes in the cell-free DNA of pregnant women at risk of preeclampsia
Novel Test Helps Detect Often-Missed Cervical Adenocarcinoma
Albert Einstein College of Medicine
Women with a high DNA methylation score would be prone to HPV infection, AIS, and ADC
FDA Approves First RSV Vaccine for Pregnant Individuals
U.S. Food and Drug Administration
According to the CDC, RSV is the leading cause of infant hospitalization in the US and warrants immediate preventive action
Innovations for Equitable Cervical Cancer Screening
Swathi Kodaikal, MSc
Accessible screening tests and inclusive management strategies could reduce cervical cancer globally
FDA Approves First Oral Treatment for Postpartum Depression
U.S. Food and Drug Administration
Multicenter clinical trials demonstrated the efficacy of Zurzuvae in women with PPD
Key Genes for Ovarian Cancer Prognosis Identified
Imperial College London
New research highlights why some women with high-grade serous ovarian cancer respond better to treatment than others
WHO Prequalifies Additional HPV Test, Accelerates Efforts Toward Cervical Cancer Elimination
World Health Organization
HPV tests perform better than alternative screening methods and help identify more patients in need of treatment
Genetic Risks for SCAD Affecting Younger Women Revealed
University Hospitals of Leicester NHS Trust
First international genome-wide association meta-analysis identifies 16 genes that exacerbate SCAD risk
Younger Women at Greater Risk of Rehospitalization after Heart Attacks
Swathi Kodaikal, MSc
Women’s health demands attention and intervention—more than ever before—to better understand the impact of various stressors
The Endocrine Society Alarmed as TX Court Bans Mifepristone
The Endocrine Society
Decision significantly impacts endocrine disease treatment, drug approval process, and access to reproductive care
Adding Immunotherapy to Chemotherapy May Boost PFS in Cancer Patients
Society of Gynecologic Oncology
Studies point to progression-free survival and clinically meaningful changes in the standard of care for patients with endometrial cancer